Delivery Order SPE2DB20D3103-SPE2DB24FM4J4
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The $2,609.26 firm fixed-price contract has a completion date of June 28, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,989.50 firm fixed-price Delivery Order, awarded on November 8, 2022, is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product. The contract has an ultimate completion date of November 9, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Multihance 529 mg/ml vials (20 ml units) under a firm fixed price contract with a ceiling value of $9,105.30. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML medical products. The contract, valued at $6,100.40, is a firm fixed-price delivery order with a completion date of September 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $5,792.88 and is a delivery order contract for the supply of a pharmaceutical product, MULTIHANCE 529MG/ML 5S. The contract has a period of performance through March 6, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,208.48, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts, including a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,666.54 to AmerisourceBergen Drug Corp for the supply of Multihance 529mg/ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of November 21, 2025, represents a non-competitive award under an existing indefinite delivery contract. The product will be delivered to the company's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,046.54 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which does not have a set-aside designation, covers the supply of a comprehensive range of medical products including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits to support military healthcare programs globally. This delivery order is part of a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...